Global Energy ETF – Buy
BetaShares Global Energy Companies is under Algo Engine buy conditions.
Fuel aims to track the performance of an index that comprises the largest energy companies (ex-Australia), hedged into Australian dollars.
23/12 Update:
FOOD ETF – Buy Signal
BetaShares Global Agriculture is under Algo Engine buy condition.
FOOD aims to track the performance of an index (before fees and expenses) that comprises the largest global agriculture companies (ex-Australia), hedged into Australian dollars.
31/12 Update:
Domino’s Pizza – Algo Buy
Domino’s Pizza Enterprises is under Algo Engine buy conditions.
Orica – Algo Buy
Orica is under Algo Engine buy conditions.
Ampol – Algo Buy
Ampol is under Algo Engine buy conditions.
Origin Energy – Buy Signal
ORG:SX is under Algo Engine buy conditions and has now been added to our model portfolio.
The strong cash flows from APLNG will offset the lower expected earnings in energy markets.
22/12 Update: ORG has now rallied over 10%
FANG ETF – Buy Signal
ETFS Fang+ is under Algo Engine buy conditions with support at $17.20
Watch Last Night’s Webinar
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
COH – Algo Buy Signal
Cochlear is now under Algo Engine buy conditions and has been added to our ASX 100 model portfolio.
We expect 10% EPS growth over the next 12 months. Although, the stock remains expensive at 40x earnings and trading on a 1.8% yield.
Since writing the above post in Dec last year, COH has rallied from $175 to a high of $257. The subsequent pullback has seen buying interest rebuild at the higher low of $210.
This is the second cluster of Algo Engine buy signals and we’ve taken the opportunity to add to our original allocation.
16/12 Update: COH remains a buy at $215.
CSL – Buy
CSL has lobbed a US$11.7bn all cash public tender offer for Switzerland based specialty drug company Vifor Pharma.
The acquisition is being funded via a combination of a private placement, SPP and cash/debt, with commencement around 18 Jan-22.
Level 17 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Send our ASX Research to your Inbox
Or start a free thirty day trial for our full service, which includes our ASX Research.